Genome Testing Market by Component, Technology, Application, Distribution Channel, End-use - Global Forecast 2025-2030- Product Image

Sale

Genome Testing Market by Component, Technology, Application, Distribution Channel, End-use - Global Forecast 2025-2030

Report
193 Pages
October 2024
Region: Global
360iResearch™
ID: 5925226

UP TO €681EUR$697USD£569GBP OFF until Dec 31^st 2024

The Genome Testing Market grew from USD 17.57 billion in 2023 to USD 19.76 billion in 2024. It is expected to continue growing at a CAGR of 13.21%, reaching USD 41.90 billion by 2030.

Genome testing, which involves sequencing and analyzing the genetic material of an individual, has a broad scope that spans personalized medicine, disease prediction, and ancestry research. It is integral for identifying susceptibility to diseases, guiding treatment decisions, and understanding genetic disorders. The necessity of genome testing stems from its ability to provide insights into genetic predispositions, enabling early intervention and personalized healthcare strategies. Key applications include oncology, where genome testing aids in tailoring chemotherapy, and rare genetic disorders, offering insights into disease mechanisms. End-use applications extend to healthcare providers, research institutions, direct-to-consumer platforms, and pharmaceutical companies leveraging genetic data for drug discovery.

The market for genome testing is significantly influenced by technological advancements, reducing costs, and increasing public awareness about genetic health. The rise of precision medicine and governmental support for genomics research further boost growth. A noteworthy opportunity lies in expanding direct-to-consumer genome testing, as more individuals seek personal genetic information for preventive health measures. Another potential growth area is genomic data integration in electronic health records, enhancing clinical decision-making. However, challenges persist, such as ethical concerns around privacy and data security, regulatory hurdles, and the need for standardized data interpretation frameworks.

Innovation in genome editing technologies, like CRISPR, offers promising avenues for advancing genome testing applications. Moreover, development in AI-driven analytics could refine genome interpretation, making it more accessible. Research into polygenic risk scores holds potential for better understanding complex diseases. Businesses may benefit from focusing on compliance with emerging regulations and investing in technologies that ensure data security and privacy. The market, characterized by rapid technological evolution, competitive dynamics, and regulatory scrutiny, requires a balanced approach, integrating novel technologies while addressing ethical concerns. Stakeholders in the genome testing market should prioritize strategic collaborations and public engagement initiatives to harness the full potential of genomic advancements.

Understanding Market Dynamics in the Genome Testing Market

The Genome Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of genetic disorders and cancer across the globe
- Growing emphasis on early disease detection & prevention
- Increasing awareness of personalized medicine
Market Restraints
- High cost associated with genomics equipment
Market Opportunities
- Technological advancements in gene sequencing and data analysis
- Rising government initiatives and fundings for boosting research activities
Market Challenges
- Complexities associated with the interpreting genetic information

Exploring Porter’s Five Forces for the Genome Testing Market

Porter’s Five Forces framework further strengthens the insights of the Genome Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Genome Testing Market

External macro-environmental factors deeply influence the performance of the Genome Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Genome Testing Market

The Genome Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Genome Testing Market

The Genome Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Genome Testing Market

The Genome Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Testing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, 23andMe, Inc, Abbott Laboratories, Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche, Ltd., Freenome Holdings, Inc., GeneDx, LLC, Genomic Testing Cooperative, Helix OpCo, LLC, Illumina, Inc., Merck KGaA, New England Biolabs, Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Takara Bio Inc, Thermo Fisher Scientific Inc., Ultima Genomics, Inc., and VWR International, LLC.

Market Segmentation & Coverage

This research report categorizes the Genome Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Consumables
- Equipment
- Software & Services
Technology
- Microarrays
- Next-Generation Sequencing
- Targeted Sequencing
- Whole Genome Sequencing
Application
- Cancer
  - Brain Cancer
  - Breast Cancer
  - Colorectal Cancer
  - Lung Cancer
  - Melanoma
  - Ovarian Cancer
  - Prostate Cancer
- Non-cancer
  - Cardiovascular Diseases
  - Neurological Disorders
  - Tumors
Distribution Channel
- Offline
- Online
End-use
- Diagnostic Laboratories
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of genetic disorders and cancer across the globe
5.1.1.2. Growing emphasis on early disease detection & prevention
5.1.1.3. Increasing awareness of personalized medicine
5.1.2. Restraints
5.1.2.1. High cost associated with genomics equipment
5.1.3. Opportunities
5.1.3.1. Technological advancements in gene sequencing and data analysis
5.1.3.2. Rising government initiatives and fundings for boosting research activities
5.1.4. Challenges
5.1.4.1. Complexities associated with the interpreting genetic information
5.2. Market Segmentation Analysis
5.2.1. Component: Ongoing advancements in equipments for high-throughput sequencing
5.2.2. Technology: Increasing preference of next-generation sequencing due to its precise and comprehensive genomic analysis
5.2.3. Application: Increasing investment for advance genome testing across
5.2.4. End-use: Rising significance of advanced genomic in diagnostic laboratories for research associated with genetic diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Genome Testing Market, by Component

6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Software & Services

7. Genome Testing Market, by Technology

7.1. Introduction
7.2. Microarrays
7.3. Next-Generation Sequencing
7.4. Targeted Sequencing
7.5. Whole Genome Sequencing

8. Genome Testing Market, by Application

8.1. Introduction
8.2. Cancer
8.2.1. Brain Cancer
8.2.2. Breast Cancer
8.2.3. Colorectal Cancer
8.2.4. Lung Cancer
8.2.5. Melanoma
8.2.6. Ovarian Cancer
8.2.7. Prostate Cancer
8.3. Non-cancer
8.3.1. Cardiovascular Diseases
8.3.2. Neurological Disorders
8.3.3. Tumors

9. Genome Testing Market, by Distribution Channel

9.1. Introduction
9.2. Offline
9.3. Online

10. Genome Testing Market, by End-use

10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals & Clinics

11. Americas Genome Testing Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Genome Testing Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Genome Testing Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Cone Health Readies for 100,000 Person Genomics Project
14.3.2. Illumina Launches Advanced Liquid Biopsy Assay to Enable Comprehensive Genomic Profiling of Solid Tumors
14.3.3. Apollo Opens Genomic Institute In Chennai, to Open Three More in 2023
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. GENOME TESTING MARKET RESEARCH PROCESS
FIGURE 2. GENOME TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. GENOME TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GENOME TESTING MARKET DYNAMICS
TABLE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENOME TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENOME TESTING MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENOME TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENOME TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENOME TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENOME TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENOME TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENOME TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENOME TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENOME TESTING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENOME TESTING MARKET SIZE, BY TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENOME TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. CANADA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 63. CANADA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 64. CANADA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. CANADA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. CHINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. CHINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. CHINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 100. CHINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 101. CHINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. CHINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. INDIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. INDIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. INDIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. INDIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 107. INDIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 108. INDIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. INDIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. JAPAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. JAPAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. JAPAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 121. JAPAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 122. JAPAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. JAPAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 159. THAILAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. THAILAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. THAILAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 163. THAILAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 164. THAILAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. THAILAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. DENMARK GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. DENMARK GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 185. DENMARK GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 186. DENMARK GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. DENMARK GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. EGYPT GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. EGYPT GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. EGYPT GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 192. EGYPT GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. FINLAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. FINLAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 200. FINLAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. FINLAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 202. FRANCE GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 203. FRANCE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. FRANCE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 206. FRANCE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 207. FRANCE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. FRANCE GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 209. GERMANY GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 210. GERMANY GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. GERMANY GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 213. GERMANY GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 214. GERMANY GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. GERMANY GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 223. ITALY GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 224. ITALY GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. ITALY GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 227. ITALY GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 228. ITALY GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. ITALY GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. NORWAY GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. NORWAY GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 248. NORWAY GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. NORWAY GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 251. POLAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 252. POLAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. POLAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 255. POLAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 256. POLAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. POLAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 258. QATAR GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 259. QATAR GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. QATAR GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 262. QATAR GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 263. QATAR GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. QATAR GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 286. SPAIN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 287. SPAIN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. SPAIN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 290. SPAIN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 291. SPAIN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SPAIN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 308. TURKEY GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. TURKEY GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 311. TURKEY GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 312. TURKEY GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. TURKEY GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM GENOME TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 328. GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 329. GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Genome Testing market, which are profiled in this report, include:

10x Genomics
23andMe, Inc
Abbott Laboratories
Agilent Technologies, Inc.
BGI Group
Bio-Rad Laboratories, Inc.
Danaher Corporation
Eurofins Scientific SE
F. Hoffmann-La Roche, Ltd.
Freenome Holdings, Inc.
GeneDx, LLC
Genomic Testing Cooperative
Helix OpCo, LLC
Illumina, Inc.
Merck KGaA
New England Biolabs, Inc.
Novogene Co, Ltd.
Oxford Nanopore Technologies PLC
PerkinElmer Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Takara Bio Inc
Thermo Fisher Scientific Inc.
Ultima Genomics, Inc.
VWR International, LLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	193
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 19.76 Billion
Forecasted Market Value ( USD ) by 2030	$ 41.9 Billion
Compound Annual Growth Rate	13.2%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3466EUR$3,545USD£2,895GBP €3851EUR$3,939USD£3,217GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6132EUR$6,272USD£5,122GBP €6813EUR$6,969USD£5,691GBP

Understanding Market Dynamics in the Genome Testing Market

Exploring Porter’s Five Forces for the Genome Testing Market

Applying PESTLE Analysis to the Genome Testing Market

Analyzing Market Share in the Genome Testing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Genome Testing Market

Strategic Recommendations for Success in the Genome Testing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Diagnostics, Personalized Medicine), By Technology (Genome Sequencing, PCR), By Region, And Segment Forecasts, 2024 - 2030

Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type (Nutrigenomics, Carrier), Technology (Whole Genome Sequencing), Distribution Channel, Region, and Segment Forecasts, 2024-2030

Mutation Detection Kits in Genome Editing Market by Technology, Type, Application, End-user, Product Type, Target Detection Method, Gene Type, Research Area - Global Forecast 2025-2030

Genome Editing Market by Technology, Application, End User - Global Forecast 2025-2030

Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033